SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008658
Filing Date
2023-05-09
Accepted
2023-05-09 07:20:43
Documents
53
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20230331x10q.htm   iXBRL 10-Q 1528237
2 EX-10.1 qure-20230331xex10d1.htm EX-10.1 68108
3 EX-31.1 qure-20230331xex31d1.htm EX-31.1 15048
4 EX-31.2 qure-20230331xex31d2.htm EX-31.2 15057
5 EX-32.1 qure-20230331xex32d1.htm EX-32.1 14738
  Complete submission text file 0001558370-23-008658.txt   5959354

Data Files

Seq Description Document Type Size
6 EX-101.SCH qure-20230331.xsd EX-101.SCH 34760
7 EX-101.CAL qure-20230331_cal.xml EX-101.CAL 44130
8 EX-101.DEF qure-20230331_def.xml EX-101.DEF 207065
9 EX-101.LAB qure-20230331_lab.xml EX-101.LAB 391569
10 EX-101.PRE qure-20230331_pre.xml EX-101.PRE 290529
47 EXTRACTED XBRL INSTANCE DOCUMENT qure-20230331x10q_htm.xml XML 907678
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 23899965
SIC: 2834 Pharmaceutical Preparations